Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Tocilizumab

Neutropenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kenzhetaeva T, et al. Experience of using genetically engineered biological drugs in children with a systemic form of JIA in the Karaganda region. Bratislavske Lekarske Listy 124 : 615-621, No. 8, 2023. Available from: URL: http://doi.org/10.4149/BLL_2023_096 Kenzhetaeva T, et al. Experience of using genetically engineered biological drugs in children with a systemic form of JIA in the Karaganda region. Bratislavske Lekarske Listy 124 : 615-621, No. 8, 2023. Available from: URL: http://​doi.​org/​10.​4149/​BLL_​2023_​096
Metadaten
Titel
Tocilizumab
Neutropenia: case report
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-44809-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Tozinameran

Case report

Azithromycin